KR101292379B1 - Ｐｄｈ 및 ｆｄｈ 효소를 발현하는 유전적으로 안정한 플라스미드 - Google Patents

Ｐｄｈ 및 ｆｄｈ 효소를 발현하는 유전적으로 안정한 플라스미드 Download PDF

Info

Publication number
KR101292379B1
KR101292379B1 KR1020117026447A KR20117026447A KR101292379B1 KR 101292379 B1 KR101292379 B1 KR 101292379B1 KR 1020117026447 A KR1020117026447 A KR 1020117026447A KR 20117026447 A KR20117026447 A KR 20117026447A KR 101292379 B1 KR101292379 B1 KR 101292379B1
Authority
KR
South Korea
Prior art keywords
seq
polypeptide
fdh
nucleic acid
sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1020117026447A
Other languages
English (en)
Korean (ko)
Other versions
KR20110135990A (ko
Inventor
조나단 바슈
토마스 프란체스키니
수오 윈 리우
슈-젠 치앙
Original Assignee
브리스톨-마이어스 스큅 컴퍼니
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 브리스톨-마이어스 스큅 컴퍼니 filed Critical 브리스톨-마이어스 스큅 컴퍼니
Publication of KR20110135990A publication Critical patent/KR20110135990A/ko
Application granted granted Critical
Publication of KR101292379B1 publication Critical patent/KR101292379B1/ko
Assigned to 아스트라제네카 아베 reassignment 아스트라제네카 아베 권리의 전부이전등록 Assignors: 브리스톨-마이어스 스큅 컴퍼니
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52—Genes encoding for enzymes or proenzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0008—Oxidoreductases (1.) acting on the aldehyde or oxo group of donors (1.2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression
    • C12N15/68—Stabilisation of the vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0012—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7)
    • C12N9/0014—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on the CH-NH2 group of donors (1.4)
    • C12N9/0016—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on the CH-NH2 group of donors (1.4) with NAD or NADP as acceptor (1.4.1)
    • C12N9/0018—Phenylalanine dehydrogenase (1.4.1.20)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
KR1020117026447A 2009-04-08 2010-04-08 Ｐｄｈ 및 ｆｄｈ 효소를 발현하는 유전적으로 안정한 플라스미드 Expired - Fee Related KR101292379B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16767609P 2009-04-08 2009-04-08
US61/167,676 2009-04-08
PCT/US2010/030404 WO2010118240A1 (en) 2009-04-08 2010-04-08 A genetically stable plasmid expressing pdh and fdh enzymes

Publications (2)

Publication Number Publication Date
KR20110135990A KR20110135990A (ko) 2011-12-20
KR101292379B1 true KR101292379B1 (ko) 2013-08-09

Family

ID=42200623

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020117026447A Expired - Fee Related KR101292379B1 (ko) 2009-04-08 2010-04-08 Ｐｄｈ 및 ｆｄｈ 효소를 발현하는 유전적으로 안정한 플라스미드

Country Status (7)

Country Link
US (1) US8158394B2 (https=)
EP (1) EP2417260A1 (https=)
JP (2) JP2012523235A (https=)
KR (1) KR101292379B1 (https=)
CN (1) CN102459610B (https=)
SG (1) SG175054A1 (https=)
WO (1) WO2010118240A1 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103965065B (zh) * 2013-02-01 2016-02-17 上海现代制药股份有限公司 沙格列汀中间体、其盐、其制备方法及其用途
WO2014134281A1 (en) * 2013-02-28 2014-09-04 Full Spectrum Laboratories Limited Biosynthesis of cannabinoids
CN103555683B (zh) * 2013-11-19 2015-11-18 南京博优康远生物医药科技有限公司 一种沙格列汀手性中间体的合成方法
WO2015087262A1 (en) 2013-12-11 2015-06-18 Ranbaxy Laboratories Limited Process for the preparation of saxagliptin and its intermediates
CN103951588B (zh) * 2014-04-30 2016-10-05 淮海工学院 一种合成沙格列汀中间体n-叔丁氧羰基-3-羟基-1-金刚烷基-d-甘氨酸的方法
US9394510B2 (en) 2014-08-25 2016-07-19 Full Spectrum Laboratories Limited Apparatus and methods for the simultaneous production of compounds
CN108795893B (zh) * 2018-06-27 2021-10-08 凯莱英医药集团（天津）股份有限公司 一种氨基酸脱氢酶突变体及其制备方法和应用
CN112391363B (zh) * 2021-01-21 2021-04-06 凯莱英生命科学技术(天津)有限公司 氨基酸脱氢酶突变体及其应用

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005106011A2 (en) 2004-04-14 2005-11-10 Bristol-Myers Squibb Company Process for preparing dipeptidyl iv inhibitors and intermediates therefor
US7420079B2 (en) * 2002-12-09 2008-09-02 Bristol-Myers Squibb Company Methods and compounds for producing dipeptidyl peptidase IV inhibitors and intermediates thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6068991A (en) * 1997-12-16 2000-05-30 Bristol-Myers Squibb Company High expression Escherichia coli expression vector
US6395767B2 (en) * 2000-03-10 2002-05-28 Bristol-Myers Squibb Company Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase IV and method
US7087418B2 (en) * 2001-12-19 2006-08-08 Bristol-Myers Squibb Company Pichia pastoris formate dehydrogenase and uses therefor
US8227228B2 (en) 2005-08-02 2012-07-24 Kaneka Corporation D-amino acid oxidase, and method for production of L-amino acid, 2-oxo acid, or cyclic imine

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7420079B2 (en) * 2002-12-09 2008-09-02 Bristol-Myers Squibb Company Methods and compounds for producing dipeptidyl peptidase IV inhibitors and intermediates thereof
WO2005106011A2 (en) 2004-04-14 2005-11-10 Bristol-Myers Squibb Company Process for preparing dipeptidyl iv inhibitors and intermediates therefor

Also Published As

Publication number Publication date
KR20110135990A (ko) 2011-12-20
EP2417260A1 (en) 2012-02-15
US20100261236A1 (en) 2010-10-14
JP2014128281A (ja) 2014-07-10
CN102459610B (zh) 2014-12-17
CN102459610A (zh) 2012-05-16
US8158394B2 (en) 2012-04-17
WO2010118240A1 (en) 2010-10-14
SG175054A1 (en) 2011-11-28
JP2012523235A (ja) 2012-10-04

Similar Documents

Publication Publication Date Title
KR101292379B1 (ko) Ｐｄｈ 및 ｆｄｈ 효소를 발현하는 유전적으로 안정한 플라스미드
US5962267A (en) Proinsulin derivative and process for producing human insulin
KR102584789B1 (ko) Adh 단백질 계열 돌연변이 및 이의 용도
JPWO2010067613A1 (ja) Ｌ−サクシニルアミノアシラーゼ、およびこれを用いたｌ−アミノ酸の製造方法
CN101068833A (zh) 产生羧基端酰胺化肽的方法
JP7549017B2 (ja) 改変ｄａａｏ及びその使用
CN1279171C (zh) N端部份为蛭素衍生物的融合蛋白在生产酵母分泌的重组蛋白中的应用
KR20190086016A (ko) L-알라닐-l-글루타민 생합성 효소를 코딩하는 유전자 및 그 용도
CN1062014C (zh) 编码人α－干扰素的重组基因、表达载体的制备方法及该干扰素的纯化
JP2023531168A (ja) インスリンデグルデク誘導体およびその製造方法と使用
CN1197876C (zh) 含有分子内伴侣样序列的嵌合蛋白及其在胰岛素生产中的应用
CN114790474B (zh) 一种索马鲁肽的制备方法
CN1924006A (zh) 一种蝎抗神经胶质瘤肽及其制备方法和应用
CN1597697A (zh) 一种人的甲状旁腺素1－34肽相关肽－Pro－Pro－[Arg11]]hPTH(1－34)－Pro－Pro
RU2453604C1 (ru) Гибридный белок (варианты), штамм бактерий escherichia coli - продуцент гибридного белка (варианты) и способ получения безметионинового интерферона альфа-2 человека
CN1181199C (zh) 地衣形芽孢杆菌l-25角蛋白酶及编码该角蛋白酶的dna
JP2020522999A (ja) グルコースオキシダーゼＣｎＧＯＤＡ及びその遺伝子ならびに使用
KR20240125984A (ko) 변형된 글루타메이트 탈수소효소 및 이의 용도
CN103275958B (zh) 一种耐有机溶剂碱性蛋白酶
CN1506375A (zh) 具有广谱抗肿瘤作用的细菌蛋白天青蛋白及其用途和含有其的药物组合物
CN1082091C (zh) 重组人肿瘤坏死因子及制备方法
CN1676166A (zh) 与人表皮生长因子受体egfr特异性结合的配体寡肽
CN1162541C (zh) 一种海葵细胞毒素基因、其编码的蛋白及应用
WO2008136014A1 (en) Cloning and expression of enterokinase and its process for production
CN101067000A (zh) 新型长效胸腺肽及其应用

Legal Events

Date Code Title Description
A201 Request for examination
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

PN2301 Change of applicant

St.27 status event code: A-5-5-R10-R11-asn-PN2301

PN2301 Change of applicant

St.27 status event code: A-5-5-R10-R11-asn-PN2301

PN2301 Change of applicant

St.27 status event code: A-5-5-R10-R14-asn-PN2301

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000

R17-X000 Change to representative recorded

St.27 status event code: A-5-5-R10-R17-oth-X000

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20160727

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20160727

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000